Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding

NCT01597531 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Difficulty recruiting patients

Conditions

Type 2 Diabetes
Gastric Banding

Interventions

DRUG: Liraglutide
DRUG: Orlistat
DRUG: Liraglutide + Orlistat

Sponsor

East Carolina University